Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for THYROGLOBULIN
- Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
- Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
- Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases
- Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
- Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) Associated Alopecia Areata
- Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
- A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
- Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome)
- Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
- Study on the Effect of Selenium Supplementation on the Structure and Function of Autoimmune Thyroiditis
- Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
- Anti-VEGF Therapy for Acute Thyroid Eye Disease
- Can Levothyroxine Treatment Reduce the Development of Cardio-metabolic Disorder in Subclinical Hypothyroidism?
- Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer
- Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer
- Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
- Anti-ESO (Cancer/Test Antigen) mTCR-transduced Autologous Peripheral Blood Lymphocytes and Combination Chemotherapy in Treating Patients With Metastatic Cancer That Expresses NY-ESO-1
- Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer
- The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
- Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer
- The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance
- Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
- Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
- The Effect of Hydroxychloroquine Treatment in Hashimoto's Thyroiditis
- Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
- Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
- Levothyroxine in Pregnant SLE Patients
- A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
- Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
- The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
- Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma
- Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
- Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
- Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
- Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
- Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA
- Thyroid Treatment Trial
- Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
- Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
- Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
- Rituximab in the Treatment of Graves' Disease
- The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy
- Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine
- Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
- Studies on Tumors of the Thyroid
Clinical trials list
click for details